Combining gene expression microarray- and cluster analysis with sequence-based predictions to identify regulators of IL-13 in allergy

Cytokine

Volumn 60, Issue 3, 2012, Pages 736-740

  Bruhn, Sören ^a   Katzenellenbogen, Mark ^a   Gustafsson, Mika ^a   Krönke, Andrea ^b   Sönnichsen, Birte ^b   Zhang, Huan ^a   Benson, Mikael ^a,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Cenix BioScience GmbH   (Germany)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergy; E2F6; Interleukin 13; Transcription factor

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CCAAT ENHANCER BINDING PROTEIN BETA; INTERLEUKIN 13; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F6;

ADULT; AHR GENE; ALLERGY; ARTICLE; CD4+ T LYMPHOCYTE; CEBPB GENE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; E2F6 GENE; GENE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; IL13 GENE; MICROARRAY ANALYSIS; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CD4-POSITIVE T-LYMPHOCYTES; CLUSTER ANALYSIS; E2F6 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-13; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, ARYL HYDROCARBON; RHINITIS, ALLERGIC, SEASONAL; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84867994625     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.08.009     Document Type: Article

References (31)

1. Brightling C.E., Saha S., Hollins F. Interleukin-13: prospects for new treatments. Clin Exp Allergy 2010, 40:42-49.
2. Tachdjian R., Al Khatib S., Schwinglshackl A., Kim H.S., Chen A., Blasioli J., et al. In vivo regulation of the allergic response by the IL-4 receptor alpha chain immunoreceptor tyrosine-based inhibitory motif. J Allergy Clin Immunol 2010, 125(5):1128-1136.
3. Kelly-Welch A.E., Hanson E.M., Boothby M.R., Keegan A.D. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003, 300(5625):1527-1528.
4. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004, 202:175-190.
5. Adcock I.M., Caramori G., Chung K.F. New targets for drug development in asthma. Lancet 2008, 20(9643):1073-1087.
6. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89(4):587-596.
7. Ouyang W., Ranganath S.H., Weindel K., Bhattacharya D., Murphy T.L., Sha W.C., et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998, 9(5):745-755.
8. Zhang D.H., Yang L., Cohn L., Parkyn L., Homer R., Ray P., et al. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 1999, 11(4):473-482.
9. Horiuchi S., Onodera A., Hosokawa H., Watanabe Y., Tanaka T., Sugano S., et al. Genome-wide analysis reveals unique regulation of transcription of Th2-specific genes by GATA3. J Immunol 2011, 186(11):6378-6389.
10. Simeone-Penney M.C., Severgnini M., Tu P., Homer R.J., Mariani T.J., Cohn L., et al. Airway epithelial STAT3 is required for allergic inflammation in a murine model of asthma. J Immunol 2007, 178(10):6191-6199.
11. Rodriguez-Galan M.C., Bream J.H., Farr A., Young H.A. Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression. J Immunol 2005, 174(5):2796-2804.
12. Wurster A.L., Tanaka T., Grusby M.J. The biology of Stat4 and Stat6. Oncogene 2000, 19(21):2577-2584.
13. Hinz M., Lemke P., Anagnostopoulos I., Hacker C., Krappmann D., Mathas S., et al. Nuclear factor kappaB-dependent gene expression profiling of hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 2002, 196(5):605-617.
14. Liu J., Arai K., Arai N. Inhibition of NFATx activation by an oligopeptide: disrupting the interaction of NFATx with calcineurin. J Immunol 2001, 167(5):2677-2687.
15. Williams K.L., Zullo A.J., Kaplan M.H., Brutkiewicz R.R., Deppmann C.D., Vinson C., et al. BATF transgenic mice reveal a role for activator protein-1 in NKT cell development. J Immunol 2003, 170(5):2417-2426.
16. Segal E., Widom J. From DNA sequence to transcriptional behaviour: a quantitative approach. Nat Rev Genet 2009, 10(7):443-456.
17. Elkon R., Linhart C., Sharan R., Shamir R., Shilo Y. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 2003, 13(5):773-780.
18. Berberich-Siebelt F., Klein-Hessling S., Hepping N., Santner-Nanan B., Lindemann D., Schimpl A., et al. C/EBPbeta enhances IL-4 but impairs IL-2 and IFN-gamma induction in T cells. Eur J Immunol 2000, 30(9):2576-2585.
19. Isshiki H., Akira S., Sugita T., Nishio Y., Hashimoto S., Pawlowski T., et al. Reciprocal expression of NF-IL6 and C/EBP in hepatocytes: possible involvement of NF-IL6 in acute phase protein gene expression. New Biol 1991, 3(1):63-70.
20. Brydon E.W., Morris S.J., Sweet C. Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol Rev 2005, 29(4):837-850.
21. Gorgoni B., Maritano D., Marthyn P., Righi M., Poli V. C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages. J Immunol 2002, 168(8):4055-4062.
22. Jones L.C., Lin M.L., Chen S.S., Krug U., Hofmann W.K., Lee S., et al. Expression of C/EBPbeta from the C/ebpalpha gene locus is sufficient for normal hematopoiesis in vivo. Blood 2002, 99(6):2032-2036.
23. Ufer M., Hasler R., Jacobs G., Haenisch S., Lachelt S., Faltraco F., et al. Decreased sigmoidal ABCB1 (P-glycoprotein) expression in ulcerative colitis is associated with disease activity. Pharmacogenomics 2009, 10(12):1941-1953.
24. Kajimura S., Seale P., Kubota K., Lunsford E., Frangioni J.V., Gygi S.P., et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 2009, 460(7259):1154-1158.
25. Ishikawa H., Fenkci V., Marsh E.E., Yin P., Chen D., Cheng Y.H., et al. CCAAT/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma. J Clin Endocrinol Metab 2008, 93(3):981-991.
26. Honma K., Kimura D., Tominaga N., Miyakoda M., Matsuyama T., Yui K. Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines in naive vs. effector/memory CD4+ T cells. Proc Natl Acad Sci 2008, 105(41):15890-15895.
27. Ramasamy A., Curjuric I., Coin L.J., Kumar A., McArdle W.L., Imboden M., et al. A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order. J Allergy Clin Immunol 2011, 128(5):996-1005.
28. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998, 12:2245-2262.
29. Kozaki K., Imoto I., Mogi S., Omura K., Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008, 68:2094-2105.
30. Trimarchi J.M., Lees J.A. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002, 3:11-20.
31. Chen C., Wells A.D. Comparative analysis of E2F family member oncogenic activity. PloS One 2007, 2(9):19.